OmniSeq News

Dr. Carl Morrison featured in Future of Personal Health

Dr. Morrison, president of OmniSeq℠ Precision Medicine Technology, is featured as a “leading voice” in precision medicine. Buffalo, NY – June 29, 2015—The digital publication Future of Personal Health focuses on precision medicine in an article entitled...

read more

OmniSeq LLC: A Unique Approach to Personalized Medicine

By Alan Rosenhoch, Featuring Carl Morrison, MD, DVM Dr. Carl Morrison is founder, president and chief scientific officer of OmniSeq LLC – a recent Roswell Park Cancer Institute spinoff genomics firm. At Roswell Park, Dr. Morrison continues in his roles as Executive...

read more

Covaris, Inc. and OmniSeq, LLC Today Announced truXTRAC™ FFPE DNA Extraction and Purification Kit as the Method of Choice for Obtaining Clinical-Grade DNA from FFPE Samples for Use with OmniSeq Target℠ Testing

WOBURN, Mass., Sept. 1, 2015 /PRNewswire/ — truXTRAC is a comprehensive novel solution for clinical-grade DNA extraction from Formalin-Fixed, Paraffin-Embedded (FFPE) tissues utilizing Covaris Adaptive Focused Acoustics® (AFA™) technology. The unique focused,...

read more

Follow Us on Twitter

Immune Report Card®: New Test Matches Patients With Immunotherapies Likely to Work Best | Roswell Park Comprehensive Cancer Center https://t.co/M3a34gfbQG

Proud that OmniSeq has met the rigorous standards needed to become an NCI-MATCH participating lab. Working hard with our colleagues at LabCorp to bring this testing to NCORP sites across the country! https://t.co/qUQTFidjek

OmniSeq Advance "All I Want": https://t.co/NwtMmpXspL via @YouTube

Congratulations to @OmniSeq on launching another innovative new #genomic test! Dr. Carl Morrison, here with team at #ASCO18: “You see a lot of studies that show promise with these additional biomarkers, and we’re testing for them right now.” https://t.co/MiUyvBPVo7

Load More...